Credit Agricole’s Novartis NVS Stock Holding History

Credit Agricole’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$954K	Buy	6,089 +453	+8%	+$67.9K	﹤0.01%	1140
2026 Q1	$861K	Buy	+5,636	New	+$864K	﹤0.01%	1109
2025 Q1	–	Sell	-243	Closed	-$23.6K	–	1312
2024 Q4	$23.6K	Hold	243	–	–	﹤0.01%	1208
2024 Q3	$27.9K	Hold	243	–	–	﹤0.01%	1181
2024 Q2	$25.9K	Hold	243	–	–	﹤0.01%	1024
2024 Q1	$22.5K	Hold	243	–	–	﹤0.01%	828
2023 Q4	$24.5K	Hold	243	–	–	﹤0.01%	814
2023 Q3	$23.4K	Hold	243	–	–	﹤0.01%	814
2023 Q2	$24.5K	Hold	243	–	–	﹤0.01%	579
2023 Q1	$22.4K	Hold	243	–	–	﹤0.01%	547
2022 Q4	$22K	Hold	243	–	–	﹤0.01%	579
2022 Q3	$18K	Hold	243	–	–	﹤0.01%	574
2022 Q2	$21K	Hold	243	–	–	﹤0.01%	569
2022 Q1	$21K	Hold	243	–	–	﹤0.01%	597
2021 Q4	$21K	Buy	+243	New	+$20.2K	﹤0.01%	599
2015 Q4	–	Sell	-11,628	Closed	-$958K	–	1447
2015 Q3	$958K	Buy	+11,628	New	+$1.03M	﹤0.01%	1020
2014 Q2	–	Sell	-9,374	Closed	-$714K	–	1632
2014 Q1	$714K	Buy	9,374 +669	+8%	+$48.7K	﹤0.01%	1076
2013 Q4	$627K	Buy	8,705 +447	+5%	+$31.1K	﹤0.01%	1134
2013 Q3	$568K	Buy	+8,258	New	+$546K	﹤0.01%	1152

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Credit Agricole's NVS Position: Q2 2026 in Review

Credit Agricole increased its Novartis (NVS) stake by 8% in Q2 2026, buying an estimated $67.9K and bringing the position to 6,089 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Credit Agricole first reported a position in NVS in Q3 2013 and has held it in 19 quarters since. The position peaked at $958K in Q3 2015. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Credit Agricole held 6,089 shares of Novartis worth $954K as of Q2 2026.
Credit Agricole bought 453 Novartis shares in Q2 2026, an estimated $67.9K.
Novartis made up ﹤0.01% of Credit Agricole's portfolio in Q2 2026, its #1140 holding.
Credit Agricole first reported a position in Novartis in Q3 2013 and has held it in 19 quarters since.
Credit Agricole's Novartis position peaked at $958K in Q3 2015.
1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.